[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global CDMO for Transdermal Patches and Oral Film Market Growth (Status and Outlook) 2024-2030

April 2024 | 114 pages | ID: G38383541B75EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

CDMO stands for Contract Development and Manufacturing Organization. In the context of transdermal patches and oral films, a CDMO specializing in these dosage forms would offer services such as formulation development, process optimization, scale-up, manufacturing, packaging, and regulatory support for pharmaceutical companies looking to outsource these aspects of their product development. These CDMOs have expertise in developing and manufacturing transdermal patches and oral films, ensuring that they meet quality standards and regulatory requirements.

The global CDMO for Transdermal Patches and Oral Film market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LPI (LP Information)' newest research report, the “CDMO for Transdermal Patches and Oral Film Industry Forecast” looks at past sales and reviews total world CDMO for Transdermal Patches and Oral Film sales in 2023, providing a comprehensive analysis by region and market sector of projected CDMO for Transdermal Patches and Oral Film sales for 2024 through 2030. With CDMO for Transdermal Patches and Oral Film sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CDMO for Transdermal Patches and Oral Film industry.

This Insight Report provides a comprehensive analysis of the global CDMO for Transdermal Patches and Oral Film landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on CDMO for Transdermal Patches and Oral Film portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CDMO for Transdermal Patches and Oral Film market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CDMO for Transdermal Patches and Oral Film and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CDMO for Transdermal Patches and Oral Film.

The market trend for Contract Development and Manufacturing Organizations (CDMO) in the transdermal patches and oral film industry is showing significant growth, with major sales regions including North America, Europe, and Asia Pacific. The market concentration is high, with a few key players dominating the industry and offering a wide range of services such as formulation development, analytical testing, and regulatory support. There are ample market opportunities for CDMOs in this sector, as the demand for innovative drug delivery systems continues to rise, driven by factors such as the increasing prevalence of chronic diseases and the need for convenient and patient-friendly dosage forms. However, there are also challenges to be aware of, such as regulatory hurdles, pricing pressures, and the need for continuous innovation to stay competitive in the market. Overall, the outlook for CDMOs in the transdermal patches and oral film market is positive, with strong growth potential and opportunities for expansion in both established and emerging markets.

This report presents a comprehensive overview, market shares, and growth opportunities of CDMO for Transdermal Patches and Oral Film market by product type, application, key players and key regions and countries.

Segmentation by type
  • Transdermal Patches
  • Oral Film
Segmentation by application
  • Pharmaceutical Company
  • Biotechnology Company
  • Generic Company
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • AdhexPharma
  • Nissha
  • Tapemark
  • tesa
  • LTS Lohmann
  • IntelGenx
  • MedPharm
  • Adhesives Research
  • Shilpa Medicare Limited
  • ROFARMA
  • Kindeva Drug Delivery
  • ProSolus
  • Altergon
  • Youwei Biotech
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global CDMO for Transdermal Patches and Oral Film Market Size 2019-2030
  2.1.2 CDMO for Transdermal Patches and Oral Film Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 CDMO for Transdermal Patches and Oral Film Segment by Type
  2.2.1 Transdermal Patches
  2.2.2 Oral Film
2.3 CDMO for Transdermal Patches and Oral Film Market Size by Type
  2.3.1 CDMO for Transdermal Patches and Oral Film Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type (2019-2024)
2.4 CDMO for Transdermal Patches and Oral Film Segment by Application
  2.4.1 Pharmaceutical Company
  2.4.2 Biotechnology Company
  2.4.3 Generic Company
2.5 CDMO for Transdermal Patches and Oral Film Market Size by Application
  2.5.1 CDMO for Transdermal Patches and Oral Film Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global CDMO for Transdermal Patches and Oral Film Market Size Market Share by Application (2019-2024)

3 CDMO FOR TRANSDERMAL PATCHES AND ORAL FILM MARKET SIZE BY PLAYER

3.1 CDMO for Transdermal Patches and Oral Film Market Size Market Share by Players
  3.1.1 Global CDMO for Transdermal Patches and Oral Film Revenue by Players (2019-2024)
  3.1.2 Global CDMO for Transdermal Patches and Oral Film Revenue Market Share by Players (2019-2024)
3.2 Global CDMO for Transdermal Patches and Oral Film Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CDMO FOR TRANSDERMAL PATCHES AND ORAL FILM BY REGIONS

4.1 CDMO for Transdermal Patches and Oral Film Market Size by Regions (2019-2024)
4.2 Americas CDMO for Transdermal Patches and Oral Film Market Size Growth (2019-2024)
4.3 APAC CDMO for Transdermal Patches and Oral Film Market Size Growth (2019-2024)
4.4 Europe CDMO for Transdermal Patches and Oral Film Market Size Growth (2019-2024)
4.5 Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas CDMO for Transdermal Patches and Oral Film Market Size by Country (2019-2024)
5.2 Americas CDMO for Transdermal Patches and Oral Film Market Size by Type (2019-2024)
5.3 Americas CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC CDMO for Transdermal Patches and Oral Film Market Size by Region (2019-2024)
6.2 APAC CDMO for Transdermal Patches and Oral Film Market Size by Type (2019-2024)
6.3 APAC CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe CDMO for Transdermal Patches and Oral Film by Country (2019-2024)
7.2 Europe CDMO for Transdermal Patches and Oral Film Market Size by Type (2019-2024)
7.3 Europe CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa CDMO for Transdermal Patches and Oral Film by Region (2019-2024)
8.2 Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size by Type (2019-2024)
8.3 Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CDMO FOR TRANSDERMAL PATCHES AND ORAL FILM MARKET FORECAST

10.1 Global CDMO for Transdermal Patches and Oral Film Forecast by Regions (2025-2030)
  10.1.1 Global CDMO for Transdermal Patches and Oral Film Forecast by Regions (2025-2030)
  10.1.2 Americas CDMO for Transdermal Patches and Oral Film Forecast
  10.1.3 APAC CDMO for Transdermal Patches and Oral Film Forecast
  10.1.4 Europe CDMO for Transdermal Patches and Oral Film Forecast
  10.1.5 Middle East & Africa CDMO for Transdermal Patches and Oral Film Forecast
10.2 Americas CDMO for Transdermal Patches and Oral Film Forecast by Country (2025-2030)
  10.2.1 United States CDMO for Transdermal Patches and Oral Film Market Forecast
  10.2.2 Canada CDMO for Transdermal Patches and Oral Film Market Forecast
  10.2.3 Mexico CDMO for Transdermal Patches and Oral Film Market Forecast
  10.2.4 Brazil CDMO for Transdermal Patches and Oral Film Market Forecast
10.3 APAC CDMO for Transdermal Patches and Oral Film Forecast by Region (2025-2030)
  10.3.1 China CDMO for Transdermal Patches and Oral Film Market Forecast
  10.3.2 Japan CDMO for Transdermal Patches and Oral Film Market Forecast
  10.3.3 Korea CDMO for Transdermal Patches and Oral Film Market Forecast
  10.3.4 Southeast Asia CDMO for Transdermal Patches and Oral Film Market Forecast
  10.3.5 India CDMO for Transdermal Patches and Oral Film Market Forecast
  10.3.6 Australia CDMO for Transdermal Patches and Oral Film Market Forecast
10.4 Europe CDMO for Transdermal Patches and Oral Film Forecast by Country (2025-2030)
  10.4.1 Germany CDMO for Transdermal Patches and Oral Film Market Forecast
  10.4.2 France CDMO for Transdermal Patches and Oral Film Market Forecast
  10.4.3 UK CDMO for Transdermal Patches and Oral Film Market Forecast
  10.4.4 Italy CDMO for Transdermal Patches and Oral Film Market Forecast
  10.4.5 Russia CDMO for Transdermal Patches and Oral Film Market Forecast
10.5 Middle East & Africa CDMO for Transdermal Patches and Oral Film Forecast by Region (2025-2030)
  10.5.1 Egypt CDMO for Transdermal Patches and Oral Film Market Forecast
  10.5.2 South Africa CDMO for Transdermal Patches and Oral Film Market Forecast
  10.5.3 Israel CDMO for Transdermal Patches and Oral Film Market Forecast
  10.5.4 Turkey CDMO for Transdermal Patches and Oral Film Market Forecast
  10.5.5 GCC Countries CDMO for Transdermal Patches and Oral Film Market Forecast
10.6 Global CDMO for Transdermal Patches and Oral Film Forecast by Type (2025-2030)
10.7 Global CDMO for Transdermal Patches and Oral Film Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 AdhexPharma
  11.1.1 AdhexPharma Company Information
  11.1.2 AdhexPharma CDMO for Transdermal Patches and Oral Film Product Offered
  11.1.3 AdhexPharma CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 AdhexPharma Main Business Overview
  11.1.5 AdhexPharma Latest Developments
11.2 Nissha
  11.2.1 Nissha Company Information
  11.2.2 Nissha CDMO for Transdermal Patches and Oral Film Product Offered
  11.2.3 Nissha CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Nissha Main Business Overview
  11.2.5 Nissha Latest Developments
11.3 Tapemark
  11.3.1 Tapemark Company Information
  11.3.2 Tapemark CDMO for Transdermal Patches and Oral Film Product Offered
  11.3.3 Tapemark CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Tapemark Main Business Overview
  11.3.5 Tapemark Latest Developments
11.4 tesa
  11.4.1 tesa Company Information
  11.4.2 tesa CDMO for Transdermal Patches and Oral Film Product Offered
  11.4.3 tesa CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 tesa Main Business Overview
  11.4.5 tesa Latest Developments
11.5 LTS Lohmann
  11.5.1 LTS Lohmann Company Information
  11.5.2 LTS Lohmann CDMO for Transdermal Patches and Oral Film Product Offered
  11.5.3 LTS Lohmann CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 LTS Lohmann Main Business Overview
  11.5.5 LTS Lohmann Latest Developments
11.6 IntelGenx
  11.6.1 IntelGenx Company Information
  11.6.2 IntelGenx CDMO for Transdermal Patches and Oral Film Product Offered
  11.6.3 IntelGenx CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 IntelGenx Main Business Overview
  11.6.5 IntelGenx Latest Developments
11.7 MedPharm
  11.7.1 MedPharm Company Information
  11.7.2 MedPharm CDMO for Transdermal Patches and Oral Film Product Offered
  11.7.3 MedPharm CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 MedPharm Main Business Overview
  11.7.5 MedPharm Latest Developments
11.8 Adhesives Research
  11.8.1 Adhesives Research Company Information
  11.8.2 Adhesives Research CDMO for Transdermal Patches and Oral Film Product Offered
  11.8.3 Adhesives Research CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Adhesives Research Main Business Overview
  11.8.5 Adhesives Research Latest Developments
11.9 Shilpa Medicare Limited
  11.9.1 Shilpa Medicare Limited Company Information
  11.9.2 Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Product Offered
  11.9.3 Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Shilpa Medicare Limited Main Business Overview
  11.9.5 Shilpa Medicare Limited Latest Developments
11.10 ROFARMA
  11.10.1 ROFARMA Company Information
  11.10.2 ROFARMA CDMO for Transdermal Patches and Oral Film Product Offered
  11.10.3 ROFARMA CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 ROFARMA Main Business Overview
  11.10.5 ROFARMA Latest Developments
11.11 Kindeva Drug Delivery
  11.11.1 Kindeva Drug Delivery Company Information
  11.11.2 Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Product Offered
  11.11.3 Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Kindeva Drug Delivery Main Business Overview
  11.11.5 Kindeva Drug Delivery Latest Developments
11.12 ProSolus
  11.12.1 ProSolus Company Information
  11.12.2 ProSolus CDMO for Transdermal Patches and Oral Film Product Offered
  11.12.3 ProSolus CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 ProSolus Main Business Overview
  11.12.5 ProSolus Latest Developments
11.13 Altergon
  11.13.1 Altergon Company Information
  11.13.2 Altergon CDMO for Transdermal Patches and Oral Film Product Offered
  11.13.3 Altergon CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
  11.13.4 Altergon Main Business Overview
  11.13.5 Altergon Latest Developments
11.14 Youwei Biotech
  11.14.1 Youwei Biotech Company Information
  11.14.2 Youwei Biotech CDMO for Transdermal Patches and Oral Film Product Offered
  11.14.3 Youwei Biotech CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
  11.14.4 Youwei Biotech Main Business Overview
  11.14.5 Youwei Biotech Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. CDMO for Transdermal Patches and Oral Film Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Transdermal Patches
Table 3. Major Players of Oral Film
Table 4. CDMO for Transdermal Patches and Oral Film Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global CDMO for Transdermal Patches and Oral Film Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type (2019-2024)
Table 7. CDMO for Transdermal Patches and Oral Film Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global CDMO for Transdermal Patches and Oral Film Market Size Market Share by Application (2019-2024)
Table 10. Global CDMO for Transdermal Patches and Oral Film Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global CDMO for Transdermal Patches and Oral Film Revenue Market Share by Player (2019-2024)
Table 12. CDMO for Transdermal Patches and Oral Film Key Players Head office and Products Offered
Table 13. CDMO for Transdermal Patches and Oral Film Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global CDMO for Transdermal Patches and Oral Film Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global CDMO for Transdermal Patches and Oral Film Market Size Market Share by Regions (2019-2024)
Table 18. Global CDMO for Transdermal Patches and Oral Film Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global CDMO for Transdermal Patches and Oral Film Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas CDMO for Transdermal Patches and Oral Film Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas CDMO for Transdermal Patches and Oral Film Market Size Market Share by Country (2019-2024)
Table 22. Americas CDMO for Transdermal Patches and Oral Film Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type (2019-2024)
Table 24. Americas CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas CDMO for Transdermal Patches and Oral Film Market Size Market Share by Application (2019-2024)
Table 26. APAC CDMO for Transdermal Patches and Oral Film Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC CDMO for Transdermal Patches and Oral Film Market Size Market Share by Region (2019-2024)
Table 28. APAC CDMO for Transdermal Patches and Oral Film Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type (2019-2024)
Table 30. APAC CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC CDMO for Transdermal Patches and Oral Film Market Size Market Share by Application (2019-2024)
Table 32. Europe CDMO for Transdermal Patches and Oral Film Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe CDMO for Transdermal Patches and Oral Film Market Size Market Share by Country (2019-2024)
Table 34. Europe CDMO for Transdermal Patches and Oral Film Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type (2019-2024)
Table 36. Europe CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe CDMO for Transdermal Patches and Oral Film Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of CDMO for Transdermal Patches and Oral Film
Table 45. Key Market Challenges & Risks of CDMO for Transdermal Patches and Oral Film
Table 46. Key Industry Trends of CDMO for Transdermal Patches and Oral Film
Table 47. Global CDMO for Transdermal Patches and Oral Film Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global CDMO for Transdermal Patches and Oral Film Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global CDMO for Transdermal Patches and Oral Film Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global CDMO for Transdermal Patches and Oral Film Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. AdhexPharma Details, Company Type, CDMO for Transdermal Patches and Oral Film Area Served and Its Competitors
Table 52. AdhexPharma CDMO for Transdermal Patches and Oral Film Product Offered
Table 53. AdhexPharma CDMO for Transdermal Patches and Oral Film Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. AdhexPharma Main Business
Table 55. AdhexPharma Latest Developments
Table 56. Nissha Details, Company Type, CDMO for Transdermal Patches and Oral Film Area Served and Its Competitors
Table 57. Nissha CDMO for Transdermal Patches and Oral Film Product Offered
Table 58. Nissha Main Business
Table 59. Nissha CDMO for Transdermal Patches and Oral Film Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Nissha Latest Developments
Table 61. Tapemark Details, Company Type, CDMO for Transdermal Patches and Oral Film Area Served and Its Competitors
Table 62. Tapemark CDMO for Transdermal Patches and Oral Film Product Offered
Table 63. Tapemark Main Business
Table 64. Tapemark CDMO for Transdermal Patches and Oral Film Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Tapemark Latest Developments
Table 66. tesa Details, Company Type, CDMO for Transdermal Patches and Oral Film Area Served and Its Competitors
Table 67. tesa CDMO for Transdermal Patches and Oral Film Product Offered
Table 68. tesa Main Business
Table 69. tesa CDMO for Transdermal Patches and Oral Film Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. tesa Latest Developments
Table 71. LTS Lohmann Details, Company Type, CDMO for Transdermal Patches and Oral Film Area Served and Its Competitors
Table 72. LTS Lohmann CDMO for Transdermal Patches and Oral Film Product Offered
Table 73. LTS Lohmann Main Business
Table 74. LTS Lohmann CDMO for Transdermal Patches and Oral Film Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. LTS Lohmann Latest Developments
Table 76. IntelGenx Details, Company Type, CDMO for Transdermal Patches and Oral Film Area Served and Its Competitors
Table 77. IntelGenx CDMO for Transdermal Patches and Oral Film Product Offered
Table 78. IntelGenx Main Business
Table 79. IntelGenx CDMO for Transdermal Patches and Oral Film Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. IntelGenx Latest Developments
Table 81. MedPharm Details, Company Type, CDMO for Transdermal Patches and Oral Film Area Served and Its Competitors
Table 82. MedPharm CDMO for Transdermal Patches and Oral Film Product Offered
Table 83. MedPharm Main Business
Table 84. MedPharm CDMO for Transdermal Patches and Oral Film Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. MedPharm Latest Developments
Table 86. Adhesives Research Details, Company Type, CDMO for Transdermal Patches and Oral Film Area Served and Its Competitors
Table 87. Adhesives Research CDMO for Transdermal Patches and Oral Film Product Offered
Table 88. Adhesives Research Main Business
Table 89. Adhesives Research CDMO for Transdermal Patches and Oral Film Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Adhesives Research Latest Developments
Table 91. Shilpa Medicare Limited Details, Company Type, CDMO for Transdermal Patches and Oral Film Area Served and Its Competitors
Table 92. Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Product Offered
Table 93. Shilpa Medicare Limited Main Business
Table 94. Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Shilpa Medicare Limited Latest Developments
Table 96. ROFARMA Details, Company Type, CDMO for Transdermal Patches and Oral Film Area Served and Its Competitors
Table 97. ROFARMA CDMO for Transdermal Patches and Oral Film Product Offered
Table 98. ROFARMA Main Business
Table 99. ROFARMA CDMO for Transdermal Patches and Oral Film Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. ROFARMA Latest Developments
Table 101. Kindeva Drug Delivery Details, Company Type, CDMO for Transdermal Patches and Oral Film Area Served and Its Competitors
Table 102. Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Product Offered
Table 103. Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Kindeva Drug Delivery Main Business
Table 105. Kindeva Drug Delivery Latest Developments
Table 106. ProSolus Details, Company Type, CDMO for Transdermal Patches and Oral Film Area Served and Its Competitors
Table 107. ProSolus CDMO for Transdermal Patches and Oral Film Product Offered
Table 108. ProSolus Main Business
Table 109. ProSolus CDMO for Transdermal Patches and Oral Film Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. ProSolus Latest Developments
Table 111. Altergon Details, Company Type, CDMO for Transdermal Patches and Oral Film Area Served and Its Competitors
Table 112. Altergon CDMO for Transdermal Patches and Oral Film Product Offered
Table 113. Altergon Main Business
Table 114. Altergon CDMO for Transdermal Patches and Oral Film Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Altergon Latest Developments
Table 116. Youwei Biotech Details, Company Type, CDMO for Transdermal Patches and Oral Film Area Served and Its Competitors
Table 117. Youwei Biotech CDMO for Transdermal Patches and Oral Film Product Offered
Table 118. Youwei Biotech Main Business
Table 119. Youwei Biotech CDMO for Transdermal Patches and Oral Film Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Youwei Biotech Latest Developments

LIST OF FIGURES

Figure 1. CDMO for Transdermal Patches and Oral Film Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CDMO for Transdermal Patches and Oral Film Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. CDMO for Transdermal Patches and Oral Film Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. CDMO for Transdermal Patches and Oral Film Sales Market Share by Country/Region (2023)
Figure 8. CDMO for Transdermal Patches and Oral Film Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type in 2023
Figure 10. CDMO for Transdermal Patches and Oral Film in Pharmaceutical Company
Figure 11. Global CDMO for Transdermal Patches and Oral Film Market: Pharmaceutical Company (2019-2024) & ($ Millions)
Figure 12. CDMO for Transdermal Patches and Oral Film in Biotechnology Company
Figure 13. Global CDMO for Transdermal Patches and Oral Film Market: Biotechnology Company (2019-2024) & ($ Millions)
Figure 14. CDMO for Transdermal Patches and Oral Film in Generic Company
Figure 15. Global CDMO for Transdermal Patches and Oral Film Market: Generic Company (2019-2024) & ($ Millions)
Figure 16. Global CDMO for Transdermal Patches and Oral Film Market Size Market Share by Application in 2023
Figure 17. Global CDMO for Transdermal Patches and Oral Film Revenue Market Share by Player in 2023
Figure 18. Global CDMO for Transdermal Patches and Oral Film Market Size Market Share by Regions (2019-2024)
Figure 19. Americas CDMO for Transdermal Patches and Oral Film Market Size 2019-2024 ($ Millions)
Figure 20. APAC CDMO for Transdermal Patches and Oral Film Market Size 2019-2024 ($ Millions)
Figure 21. Europe CDMO for Transdermal Patches and Oral Film Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size 2019-2024 ($ Millions)
Figure 23. Americas CDMO for Transdermal Patches and Oral Film Value Market Share by Country in 2023
Figure 24. United States CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC CDMO for Transdermal Patches and Oral Film Market Size Market Share by Region in 2023
Figure 29. APAC CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type in 2023
Figure 30. APAC CDMO for Transdermal Patches and Oral Film Market Size Market Share by Application in 2023
Figure 31. China CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 35. India CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe CDMO for Transdermal Patches and Oral Film Market Size Market Share by Country in 2023
Figure 38. Europe CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type (2019-2024)
Figure 39. Europe CDMO for Transdermal Patches and Oral Film Market Size Market Share by Application (2019-2024)
Figure 40. Germany CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 41. France CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size Market Share by Application (2019-2024)
Figure 48. Egypt CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country CDMO for Transdermal Patches and Oral Film Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 54. APAC CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 55. Europe CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 57. United States CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 58. Canada CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 59. Mexico CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 60. Brazil CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 61. China CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 62. Japan CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 63. Korea CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 65. India CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 66. Australia CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 67. Germany CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 68. France CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 69. UK CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 70. Italy CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 71. Russia CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 72. Spain CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 73. Egypt CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 74. South Africa CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 75. Israel CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 76. Turkey CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries CDMO for Transdermal Patches and Oral Film Market Size 2025-2030 ($ Millions)
Figure 78. Global CDMO for Transdermal Patches and Oral Film Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global CDMO for Transdermal Patches and Oral Film Market Size Market Share Forecast by Application (2025-2030)


More Publications